Glyburide metabolism by placentas of healthy and gestational diabetics

American Journal of Perinatology

Volumn 25, Issue 3, 2008, Pages 169-174

  Jain, Sangeeta ^a   Zharikova, Olga L ^a   Ravindran, Selvan ^a   Nanovskya, Tatiana N ^a   Mattison, Donald R ^b   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Diabetic diet; Gestational diabetes; Glyburide; Placental metabolism

Indexed keywords

3 HYDROXYCYCLOHEXYL GLYBURIDE; 4 HYDROXYCYCLOHEXYL GLYBURIDE; DRUG METABOLITE; GLIBENCLAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DIABETIC PATIENT; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETER; MASS SPECTROMETRY; MICROSOME; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; CHROMATOGRAPHY, LIQUID; DIABETES, GESTATIONAL; DIABETIC DIET; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MASS SPECTROMETRY; MICROSOMES; PLACENTA; PREGNANCY;

EID: 41149137136     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1061503     Document Type: Article

References (23)

1. Coustan DR. Gestational diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda, MD: NIDDK; 1995, NIH Publication No. 95-1468:703-717
2. Berkus MD, Conway D, Langer O. The large fetus. Clin Obstet Gynecol 1999;42:766-784
3. Rochon M, Rand L, Roth L, Gaddipati S. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 2006;195:1090-1094
4. Belser F, Brogli H, Constam G, Zollikofer H. Testing a new antidiabetic (Glibenclamide) in hospitalized and ambulatory diabetics. Schweiz Rundsch Med Prax 1970;59:598-601
5. Davis SN. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Brunton L, Parker K, Buxton I, Blumenthal D, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; 2006:1634
6. Christ OE, Heptner W, Rupp W. Investigations of absorption, excretion and metabolism in man after administration of 14C-labelled HB 419. Horm Metab Res 1969;1(supp 1):149-153
7. Kirchheiner J, Brockmoller J, Meineke I, et al. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther 2002;71:286-296
8. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165:807-812
9. Nanovskaya TN, Nekhayeva I, Hankins GD, Ahmed MS. Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol 2006;72:632-639
10. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-274
11. Rydberg T, Wahlin-Boll E, Melander A. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography. J Chromatogr 1991;564:223-233
12. Ravindran S, Zharikova OL, Hill RA, Nanovskaya TN, Hankins GD, Ahmed MS. Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. Biochem Pharmacol 2006;72:1730-1737
13. Rupp W, Christ O, Heptner W. Resorption, Ausscheidung und Metabolismus nach intravenoser und oraler gabe von HB 419-14C and menschen. Arzneimittelforschung 1969;19:1428-1434
14. Kim KA, Park JY. Inhibitory effect of glyburide on human cytochrome P450 isoforms in human liver microsomes. Drug Metab Dispos 2003;31:1090-1092
15. Hill RA, Rudra S, Peng B, et al. Hydroxyl-substituted sulfonylureas as potent inhibitors of specific [3H] glyburide binding to rat brain synaptosomes. Bioorg Med Chem 2003;11:2099-2113
16. American Diabetic Association. Gestational diabetes mellitus (position statement). Diabetes Care 2002;25(suppl 10):s94-96
17. Deshmukh SV, Nanovskaya TN, Ahmed MS. Aromatase is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther 2003;306:1099-1105
18. Nanovskaya TN, Deshmukh SV, Nekhayeva IA, Zharikova OL, Hankins GD, Ahmed MS. Methadone metabolism by human placenta. Biochem Pharmacol 2004;68:583-591
19. Zharikova OL, Ravindran S, Nanovskaya TN, Hill RA, Hankins GD, Ahmed MS. Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon. Biochem Pharmacol 2007;73:2012-2019
20. Kasai K, Shik SS, Yoshida Y. Production and localization of human prolactin in placenta and decidua in early and term normal pregnancy. Int Biol Res Pregnancy 1982;3:25-29
21. Taylor CM, Stevens H, Anthony FW, Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotropin production in the trophoblast-derived cell lines: JEG, JAr, and BeWo. Placenta 1997;18:451-458
22. Yang W, Ahn H, Hinrichs M, et al. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J Reprod Immunol 2003;60:53-60
23. Nanovskaya T, Nekhayeva I, Karunaratne N, Audus K, Hankins GD, Ahmed MS. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 2005;69:1869-1878